Xanadu Quantum Technologies
XNDU
1.70
-0.12
-6.59%
Xanadu Quantum Technologies
US · XNDU
#3059 by market cap
Listed 1970
1.70
-0.12
-6.59%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:49
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.69, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 3 years
Latest year +204.47% YoY
Margins
- Gross margin
- 92.18%
- Operating margin
- -1,501.45%
- Net margin
- -1,530.58%
Key ratios & quality
- Enterprise valuei
- 540.00M
- Altman Z-Scorei
- 2.69
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 1.87M | 1.11M | 3.37M |
| Gross profit | 1.41M | 782.47K | 3.11M |
| Selling & admin expenses | 5.01M | 5.51M | 12.12M |
| Research & development | 26.92M | 27.33M | 40.33M |
| Operating profit | -31.43M | -35.25M | -50.61M |
| Pretax profit | -26.83M | -32.03M | -51.60M |
| Tax | -- | -- | -- |
| Net profit | -26.83M | -32.03M | -51.60M |
| Basic EPS | 0 | 0 | 0 |
| Diluted EPS | -0.09 | -0.11 | -0.17 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 1.06M | 987.00K | 628.96K | 2.83M | 1.51M | 1.31M |
| Gross profit | 997.00K | 935.00K | 527.39K | 2.72M | 1.38M | 1.21M |
| Selling & admin expenses | 2.56M | 4.27M | 3.16M | 11.16M | 11.60M | 10.05M |
| Research & development | 13.01M | 15.30M | 2.01M | 17.35M | 19.72M | 25.56M |
| Operating profit | -15.52M | -20.70M | -1.63M | -23.27M | -29.99M | -34.63M |
| Pretax profit | -15.14M | -20.30M | -3.95M | -20.60M | -42.05M | -32.20M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -15.14M | -20.30M | -3.95M | -20.60M | -42.05M | -32.20M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.05 | -0.07 | -0.01 | -0.28 | -0.14 | -0.11 |
Balance sheet
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total current assets | 93.19M | 62.97M | 29.36M |
| Cash & ST investments | 88.54M | 54.08M | 11.80M |
| Inventory | 8.29K | 2.23M | 6.09M |
| Total assets | 113.81M | 81.36M | 51.55M |
| Total current liabilities | 2.33M | 3.75M | 6.55M |
| Short-term debt | 758.33K | 693.98K | 784.15K |
| Long-term debt | 5.13M | 11.15M | 21.90M |
| Total liabilities | 14,385,647.52 | 20,394,512.22 | 33,702,286.73 |
| Total equity | 99.43M | 60.96M | 17.85M |
| Retained earnings | -67.59M | -94.51M | -150.63M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 41.10M | 29.36M | 290.42M | 331.22M | 311.19M |
| Cash & ST investments | -- | 25.94M | 11.80M | 272.47M | 312.78M | 286.47M |
| Inventory | -- | 6.52M | 6.09M | 6.11M | 5.72M | 3.93M |
| Total assets | -- | 62.76M | 51.55M | 319.04M | 384.01M | 375.79M |
| Total current liabilities | -- | 7.70M | 6.55M | 20.24M | 12.97M | 26.81M |
| Short-term debt | -- | 754.45K | 784.15K | 1.06M | 1.18M | 1.75M |
| Long-term debt | -- | 18.59M | 21.90M | 30.03M | 32.41M | 33.01M |
| Total liabilities | -- | 31,571,043.65 | 33,702,286.73 | 57,063,000.00 | 70,934,000.00 | 85,848,000.00 |
| Total equity | -- | 31.19M | 17.85M | 261.98M | 313.08M | 289.94M |
| Retained earnings | -- | -131.69M | -150.63M | -228.31M | -270.37M | -302.56M |
Cash flow
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | -22.27M | -29.08M | -49.68M |
| Depreciation & amortization | 3.41M | 3.96M | 4.92M |
| Free cash flow | -30.13M | -33.73M | -56.15M |
| Dividends paid | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- |
| Ending cash balance | 88.54M | 54.08M | 11.80M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | -11.08M | -15.74M | -6.57M | -7.04M | -23.60M | -21.26M |
| Depreciation & amortization | 1.49M | 1.92M | 14.08K | 1.78M | 1.98M | 2.19M |
| Free cash flow | -15.13M | -17.44M | -5.45M | -7.56M | -30.23M | -30.05M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | 263.60M | 67.15M | 0 |
| Ending cash balance | 50.59M | 36.11M | 11.80M | 272.47M | 312.78M | 286.47M |
Returns & efficiency
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROE %i | -- | -- | -- |
| ROA %i | -23.57 | -32.82 | -77.64 |
| ROIC %i | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | -1,682.01 | -3,184.14 | -1,501.45 |
| FCF / sales %i | -- | -- | -- |
| Current ratioi | 39.93 | 16.78 | 4.48 |
| Quick ratioi | 38.41 | 14.65 | 2.86 |
| Debt / assetsi | 11.26 | 21.31 | 54.19 |
| LT debt / equityi | -- | -- | -- |
| Interest coveragei | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -22.90 | -27.76 | -117.57 |
| ROA %i | -- | -64.16 | -77.64 | -18.80 | -22.63 | -45.06 |
| ROIC %i | -- | -- | -- | -20.01 | -23.35 | -77.95 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -1,717.31 | -1,501.45 | -1,110.39 | -1,268.38 | -1,426.08 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | -- | 5.34 | 4.48 | 14.35 | 25.54 | 11.61 |
| Quick ratioi | -- | 3.52 | 2.86 | 13.65 | 24.38 | 10.89 |
| Debt / assetsi | -- | 39.24 | 54.19 | 11.88 | 15.40 | 16.18 |
| LT debt / equityi | -- | -- | -- | 14.06 | 18.51 | 20.36 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Professional services100.00%
Quote time 2026-11-20 19:49:23 · For reference only, not investment advice and not tailored to your situation.
Xanadu Quantum Technologies discussion 0 comments